InvestorsHub Logo
icon url

geocappy1

05/21/12 7:51 PM

#80353 RE: Thurly #80352

Have there not been many instances of AA subject to a phIII still having to be run?
icon url

entdoc

05/21/12 8:05 PM

#80355 RE: Thurly #80352

The recent trial data could very well have attained statistical significance, and it is wholly unrealistic to think Rob Garnick would endorse data that has not been adequately vetted. Simply won't happen. didn't happen. On the other hand, it is not clear why they would release data without fundamental statistical analysis included with it because it takes only minutes to accomplish. Several thoughts/explanations about that, but one is that it does tend to discredit any idea that the corporation is withholding and timing the release of important information. In the unlikely case the data is proven to be insignificant statistically, it would be ethically and investigationally unacceptable. I think we're okay here, and, in fact, bought some shares this afternoon for the first time in a long time. It seems almost inevitable that we are going to see some signicant overall survial data. Almost, I said.
icon url

jakedogman1

05/21/12 9:06 PM

#80357 RE: Thurly #80352

you still run a phase III with AA. The fda was a little lax but after some blowups, they woke up.